| Directive Launches Expanded Communications Division, Bringing Performance Principles to B2B PR, Social and Influencer Marketing |
Globe Newswire |
09/09 |
07:04 |
| U.S. Critical Minerals enters into agreements to merge with Nova Resources and acquire the historic McAllister tantalum mine and mill in Alabama |
Globe Newswire |
09/09 |
07:02 |
| Aya Gold & Silver Announces Updated PEA for Boumadine: After-Tax NPV Doubles to $3.5B with 93% IRR |
Globe Newswire |
09/09 |
07:00 |
| Destination XL Group, Inc. Reports Second Quarter Financial Results |
Globe Newswire |
09/09 |
07:00 |
| Remix Therapeutics Appoints Nicole Sweeny as Chief Commercial Officer |
Globe Newswire |
09/09 |
07:00 |
| Accumulus Technologies Announces Acquisition by Eir Partners to Accelerate Next Phase of Growth |
Globe Newswire |
09/09 |
07:00 |
| Honoring HR Leadership: American Express’s Monique Herena and HiBob’s Nirit Peled-Muntz Take Top Honors |
Globe Newswire |
09/09 |
07:00 |
| Xanadu and ASML Announce Collaboration to Advance Lithography for Photonic Quantum Hardware |
Globe Newswire |
09/09 |
07:00 |
| Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Rackspace Technology, Inc. (RXT), Capricor Therapeutics, Inc. (CAPR), and Wise Group plc (WSE) Announced by Holzer & Holzer, LLC |
Globe Newswire |
09/09 |
07:00 |
| ODDITY Tech Reports Second Quarter 2026 Results, Expects Sequential Revenue Improvement in the Third Quarter |
Globe Newswire |
09/09 |
07:00 |
| Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment |
Globe Newswire |
09/09 |
07:00 |
| SunHydrogen CTO Details Path from Demonstrated Module Performance to Commercialization |
Globe Newswire |
09/09 |
07:00 |
| Solstice Oncology Launches with $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy |
Globe Newswire |
09/09 |
07:00 |
| Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027 |
Globe Newswire |
09/09 |
07:00 |
| Lightbridge Secures Access to Idaho National Laboratory's Advanced Test Reactor Loop Facility to Irradiate Clad Lightbridge Fuel™ Rodlets Under Prototypic Commercial Reactor Conditions |
Globe Newswire |
09/09 |
07:00 |
| Beeline Medicines Announces Positive Topline Results from Global Phase 2 Study of Afimetoran in Systemic Lupus Erythematosus |
Globe Newswire |
09/09 |
07:00 |
| Operative Launches Unified Platform to Transform Advertising & Broadcast Management |
Globe Newswire |
09/09 |
07:00 |
| LifeStance Health Group Announces Launch of Secondary Public Offering |
Globe Newswire |
09/09 |
07:00 |
| Amplify ETFs Recognized with Two 2026 ETF Express Award Nominations |
Globe Newswire |
09/09 |
07:00 |
| Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes |
Globe Newswire |
09/09 |
07:00 |
| Digital Substations Market Size, Share, Insights, Competitive Intelligence, Demand |
Globe Newswire |
09/09 |
06:53 |
| INV Legal Notice: BFA Law Notifies Innventure Investors that Lost Money of the Imminent October 27 Securities Fraud Class Action Deadline |
Globe Newswire |
09/09 |
06:36 |
| RXT Legal Notice: BFA Law Notifies Rackspace Technology Investors that Lost Money of the Imminent September 28 Securities Fraud Class Action Deadline |
Globe Newswire |
09/09 |
06:36 |
| MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management |
Globe Newswire |
09/09 |
06:30 |
| EarthDaily Awarded Government of Canada National Master Standing Offer for Commercial Satellite Imagery |
Globe Newswire |
09/09 |
06:30 |
